New Drugs4 min read
Retatrutide: The Triple Agonist That Lost 71 lbs in Trials
Retatrutide is the drug that may redefine how the medical world thinks about weight loss. In one Phase 3 clinical trial, participants lost an average of 71.2 lbs (32.3 kg) over 68...
W
WeightEasy Editorial Team